HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myopia reduction using corneal refractive therapy contact lenses.

AbstractPURPOSE:
The Paragon corneal refractive therapy (CRT) lens provides a temporary reduction in myopia by molding the cornea while sleeping. This study presents our initial experience in 20 patients fit with the CRT lens.
METHODS:
Myopic patients with a spherical correction between -1.00 and -7.75 diopters (D) and astigmatism less than 1.62 D were fit and followed for an average of 5.1 months.
RESULTS:
Patients whose initial refraction was between -1.00 and -3.00 D achieved an average of 1.50 D myopic correction; those between -3.25 and -6.00 achieved an average of 2.9 D myopic correction; and those greater than -6.00 D averaged 5.8 D of correction. Uncorrected visual acuity improved an average of 7.7 lines. One hundred percent achieved 20/40 or better vision, and 55% achieved 20/20 vision. Fifty-five percent were within 0.50 D of plano, and 84% were within 1.00 D of plano. There was an overall 80% success rate.
CONCLUSIONS:
The CRT lens is an effective modality for temporary myopic correction for a restricted subset of myopic candidates. Those with a spherical manifest refraction between -1.00 and -6.00 D and up to 1.50 D of astigmatism can expect a good outcome with these lenses.
AuthorsBruce H Koffler, Vivien M Smith
JournalEye & contact lens (Eye Contact Lens) Vol. 30 Issue 4 Pg. 223-6; discussion 230 (Oct 2004) ISSN: 1542-2321 [Print] United States
PMID15499255 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Contact Lenses
  • Cornea (physiopathology)
  • Corneal Topography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myopia (physiopathology, therapy)
  • Prosthesis Design
  • Refraction, Ocular (physiology)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: